Evidence map›Paper›PMID 40735433›Full record

ArticleJournal of arrhythmia2025

Impact of Ablation Targeting Atrial Drivers and Fragmented Potentials on Long-Standing Persistent Atrial Fibrillation: A Retrospective Study.

Yuma Gibo, Morio Ono, Yui Koyanagi, Katsuya Yoshihiro, Soichiro Usumoto, Toshihiko Gokan, Toshitaka Okabe, Naoei Isomura, Mitunori Muto, Masaru Shiigai and 2 more

Abstract read
In one paragraph

Article in Journal of arrhythmia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yuma GiboDivision of Cardiology Showa University Northern Yokohama Hospital Yokohama Kanagawa Japan.ORCID https://orcid.org/0009-0002-8360-1946
Morio OnoDivision of Cardiology Kikuna Memorial Hospital Yokohama Kanagawa Japan.ORCID https://orcid.org/0000-0003-2233-2375
Yui KoyanagiDivision of Cardiology Showa University Northern Yokohama Hospital Yokohama Kanagawa Japan.
Katsuya YoshihiroDivision of Cardiology Showa University Northern Yokohama Hospital Yokohama Kanagawa Japan.
Soichiro UsumotoDivision of Cardiology Showa University Northern Yokohama Hospital Yokohama Kanagawa Japan.
Toshihiko GokanDivision of Cardiology Kikuna Memorial Hospital Yokohama Kanagawa Japan.
Toshitaka OkabeDivision of Cardiology Showa University Northern Yokohama Hospital Yokohama Kanagawa Japan.
Naoei IsomuraDivision of Cardiology Showa University Northern Yokohama Hospital Yokohama Kanagawa Japan.
Mitunori MutoDivision of Cardiology Kikuna Memorial Hospital Yokohama Kanagawa Japan.
Masaru ShiigaiDivision of Cardiology Kikuna Memorial Hospital Yokohama Kanagawa Japan.
Junko HonyeDivision of Cardiology Kikuna Memorial Hospital Yokohama Kanagawa Japan.
Masahiko OchiaiDivision of Cardiology Showa University Northern Yokohama Hospital Yokohama Kanagawa Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Long-standing persistent atrial fibrillation (AF) often shows resistance to pulmonary vein isolation (PVI) alone. This study aimed to compare the outcomes of catheter ablation targeting electrophysiological substrates versus conventional PVI in patients with long-standing persistent AF. Methods: This retrospective study included 105 patients with long-standing persistent AF who underwent initial catheter ablation between June 2021 and June 2023. After propensity score matching ( Results: Procedure times were longer in the driver and fragmented potentials group (166.1 ± 35.9 vs. 140.7 ± 50.4 min, Conclusions: Ablation targeting atrial drivers and fragmented potentials demonstrated a trend toward improved clinical outcomes compared to conventional PVI alone, with reduced AF recurrence and PAC burden. The bottom region of the left atrium appears to be a significant therapeutic target for improving long-term success in long-standing persistent AF ablation.

Indexed as

atrial fibrillationCARTOFINDERcatheter ablationdriversfragmented

Identifiers

PMID40735433
PMCPMC12304733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.